Related Articles
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma
Identification of a novel HLA-A*02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients
Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides